We are Compass Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first clinical development programme is researching investigational COMP360 psilocybin treatment for patients with treatment-resistant depression.
We want to transform the patient experience in mental health care.
Delix Therapeutics is applying modern tools of pharmaceutical development to some of nature's most ancient therapies, psychedelics. Through its discovery platform, Delix has identified a new class of non-hallucinogenic versions of psychedelic compounds with favorable safety and therapeutic profiles. Delix is rapidly advancing these psychoplastogen compounds through preclinical and clinical development, with the goal of one day alleviating mental suffering through its FDA-approved, take-home medicines.
NUVI provides real-time solutions for enterprise brands to lead rather than react in social and across the web. NUVI enables organizations the power to own their conversations through industry-leading enterprise solutions for full lifecycle marketing across every content touchpoints - from listening and sentiment to planning, development, production, and distribution through monitoring and analysis.
Staffed with top-talent across the nation, NUVI provides a world-class brand management platform equipped with solutions as unique as each brand we serve. Built on the principle of creating engaged brand communities, NUVI powers teams with end-to-end collaborative solutions that make social management synergistic and scalable.
Get contact details of over 700M profiles across 60M
companies – all with industry-leading accuracy. Sales and Recruiter users, try out our
Email Finder Extension.
Find business and personal emails and mobile phone numbers
with exclusive coverage across niche job titles, industries, and more
for unparalleled targeting. Also
available via our
Contact Data API.